10 results
8-K
EX-2.1
EYPT
EyePoint Pharmaceuticals Inc
18 May 23
EyePoint Pharmaceuticals Announces Sale of YUTIQ® to Alimera Sciences, Inc. for $82.5 Million Cash Plus Royalties
7:06am
threatened claim or lawsuit or legal proceeding of a Third Party against EyePoint alleging that the EyePoint Licensed Technology or the EyePoint
8-K
EX-99.1
jy21ez46hlw
2 Aug 12
Other Events
12:00am
8-K
EX-99.4
x0dp3
19 Jan 11
Other Events
12:00am
- Prev
- 1
- Next